Abstract
Purpose of Review
The term “nitrogen oxides” refers to a group of molecules composed of nitrogen and oxygen. Sources of human exposure are varied ranging from environmental (acid rain), occupational (combustion of fossil fuels), and dietary to endogenously generated. Nitrogen oxides have a long association with human diseases including cancer. The goal of this review is to give a brief overview of the biological sources, relevant biological reactions, and the associations with cancer of several biologically relevant nitrogen oxides categorized based on the oxidation state of the nitrogen.
Recent Findings
The chemical reactivity of nitrogen oxides as well as their cellular distribution and microenvironmental characteristics determine the downstream biological or pathobiological effects of nitrogen oxides. Some species may react directly at the site of exposure or production, while others can be transported systemically and become metabolized to more reactive species at distant locations. The roles of nitrogen oxides in cancer biology are often contradictory due to the complexity and diversity of their biological effects.
Summary
Nitrogen oxides can participate in both causative and curative mechanisms of tumor biology. The appreciation of the high complexity and diversity of the biological effects of these reactive species in biological system will prompt our fundamental understanding of their roles in cancer and our search for improved and novel therapeutic strategies.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Under biological conditions, the term reactive nitrogen species (RNS) is often used in general to describe a collection of reactive nitrogen oxides. The most biologically active and relevant RNS are listed in Table 1 and Fig. 1a. Human exposure to nitrogen oxides occurs from various sources including environmental (air, water), dietary, or endogenous synthesis. These inorganic molecules exist in the forms of gasses, ions, and free radicals with various degrees of reactivity (Fig. 1b). The source of the RNS will partially dictate the anatomical and cellular locations of human exposure (lung, stomach vs. cytosol, nuclear). In terms of human health, exposure to RNS can have both beneficial and deleterious consequences. Physiologic and pathologic effects of RNS result from their ability to directly chemically modify macromolecules via oxidation/reduction reactions or indirectly through the induction of signal transduction pathways. In many cases, it is not the initiating RNS that is responsible for downstream phenotypic effects but rather it is due to the formation of adducts on macromolecules containing nitrogen oxide functional groups. Although RNS have been associated with the etiologies of numerous diseases, herein we will focus on their roles in cancer. Like most pathologies associated with RNS, the role(s) of RNS in cancer is multifaceted and often contradictory. The functional consequences of RNS depend on microenvironmental conditions and the phenotypic makeup of the cell as well as the duration and concentration of RNS exposure.
Nitrate (NO3 −, Oxidation State +5)
Biological Sources
The major endogenous source of nitrate (NO3 −) is nitric oxide (NO) [1]. In fact nitrate formation represents the dominant metabolic route for NO removal in the vascular compartment [2]. In the lumen of blood vessel, NO reacts with hemoglobin at the ferrous heme center and undergoes a diffusion-controlled two-electron oxidation to yield nitrate (Rxn. 1) [3]. Other nitrogen oxide derivatives can be converted to nitrate too. The oxidation of nitrite by oxyhemoglobin in red blood cells (Rxn. 2), the decomposition of peroxynitrite at lower pH (Rxn. 3), and the decomposition of dinitrogen tetraoxide (N2O4) formed by the dimerization of nitrogen dioxide radical (•NO2, Rxn. 4), all give rise to nitrate [4,5,6]. Considerable amount of our daily nitrate exposure comes from diet. Green leafy vegetables account for the major dietary source of nitrate [7].
Relevant Biological Reactions
Nitrate has long been viewed as inert end product of NO metabolism. We now know that nitrate can be reduced back to nitrite by commensal bacteria in the oral cavity and the gastrointestinal tract (Rxn. 5), which represents the bioactivation pathway of dietary nitrate. The reduction of nitrate may also be carried out by xanthine oxidoreductase (XOR) in liver to a lesser extent [8].
Association with Cancer
Health concerns regarding dietary nitrate were raised largely because of its intragastric conversion to nitrosamines (R2NNO), which could be carcinogenic and lead to gastric carcinoma [9]. For decades, numerous animal and in-human studies have been conducted to explore the potential link between nitrate and cancer, yet the results are still inconclusive [10]. No significant evidence suggests the correlation of nitrate intake with increased risk of cancer. A recent meta-analysis of 49 epidemiological studies on the association of dietary nitrate with cancer risk revealed that nitrate intake is inversely associated with gastric cancer risk [11]. Furthermore, numerous beneficial effects of nitrate (and nitrite) in lowering blood pressure and protecting against cardiac and liver ischemia–reperfusion injury have been discovered [12,13,14]. This is consistent with the fact that fruits and vegetables rich in nitrates are associated with lower risk in developing cardiovascular diseases [15].
Peroxynitrite (ONOO−, Oxidation State +5)
Biological Sources
Peroxynitrite, a strong oxidant and nucleophile, is the product of the bimolecular reaction between two biologically relevant free radicals; nitric oxide (•NO) and superoxide (O2˙−) [16]. With a rate constant of 6 × 1010 M−1 s−1, this reaction is extremely rapid and diffusion-controlled. Maximal ONOO− formation occurs when the flux rates of the two reactants •NO and O2˙− are at a ratio of 1:1 [17,18,19]. At physiological pH (7.4), ONOO− will exist in instantaneous equilibrium with its conjugate acid peroxynitrous acid (ONOOH, pKa = 6.8) since protonation is rapid (Rxn. 6).
When the ratio of •NO to O2˙− is not 1:1, the species in excess can further react with ONOO− itself resulting in the formation of other nitrosating or oxidizing species. The reaction of •NO with ONOO− tends to form nitrosating species such as dinitrogen trioxide (N2O3) [20], whereas the reaction of O2˙− with ONOO− forms less well-characterized species.
Relevant Biological Reactions
Once formed, there are two routes for ONOOH decomposition: isomerization to form the stable and unreactive nitrate anion (NO3 −) (Rxn. 3), and hemolysis to yield the oxidizing radical nitrogen dioxide (•NO2) and hydroxyl (•OH) (Rxn. 7).
Another important reaction of ONOO− is with carbon dioxide (CO2). Carbon dioxide is relatively ubiquitous in cellular environments undergoing active metabolism, and when concentrations are sufficiently high, the predominant reaction of ONOO− is with CO2. Again, there are two outcomes from this reaction: the formation of the strong oxidants •NO2 and carbonate anion radical (CO3˙−) (Rxn. 8) and the catalyzed isomerization to form nitrate (Rxn. 9) [21, 22].
An important point about the formation of ONOO− is that both of the reactants (•NO and O2˙−) are neither strong oxidants nor strong reductants. Peroxynitrite and peroxynitrous acid, however, are strong oxidants that can further decompose into three other highly oxidizing species (•NO2, CO3˙−, and •HO). In addition to these species being strong oxidants, •NO2 is a nitrating species associated with the formation of 3-nitrotyrosine (3-NT, see the “Nitrogen dioxide (˙NO2, Oxidation State +4)” section). Due to the generation of numerous highly reactive intermediates, the reaction of •NO with O2˙− to form ONOO− is considered to have mostly deleterious biological consequences [23].
Association with Cancer
Since generation of ONOO− results in the formation of strong oxidizing species, the main outcome is damage to macromolecules such as nucleic acids and proteins. Peroxynitrite, therefore, is thought to contribute to the etiology of cancer which is largely a disease of genetic mutations. In addition to causing oxidative stress, however, another effect of ONOO− formation is the savaging of NO. The reaction of NO with O2˙− is more rapid than the reaction of NO with almost any other biological target. Therefore, when there is sufficient O2˙− generation, the steady-state concentration of NO will be dramatically diminished. As NO is an important signaling molecule, reduction in its bioavailability due to ONOO− formation can have significant phenotypic and pathological consequences [24].
Studies on cancer cells have shown that peroxynitrite can activate signaling cascades such as nuclear factor kappa beta (NF-κB) via nitration of its inhibitory protein kappa B alpha (IκBα) [25]. In patients with colorectal carcinoma, both 3-nitrotyrosine and nitrate/nitrite levels were significantly higher in the plasma and tumor tissues suggesting peroxynitrite had been generated [26]. Another study on human metastatic colorectal carcinoma in the liver concluded that the cancer proliferation was due to high measured NOS2 expression and 3-NT adducts in the hepatocytes adjacent to metastatic tumor [27]. Samples from human malignant glinoma patients showed elevated levels of 3-NT as well as nitration of the tumor suppressor protein p53 which were suggested to contribute to tumor progression [28]. In human melanoma patients, high levels of 3-NT in primary tumors correlated to an advanced disease progression (Breslow thickness ≥ 2 mm) [29]. Another study demonstrated that NOS2 and 3-NT expression in melanoma cells strongly correlated with poor survival in patients with stage 3 disease [30].
Nitrogen Dioxide (•NO2, Oxidation State +4)
Biological Sources
Nitrogen dioxide is a highly reactive reddish-brown gas whose color gives rise to the characteristic appearance of urban smog. Nitrogen dioxide is a free radical derived from environmental contaminants such as tobacco smoke, indoor smoke from cooking, and emissions from vehicle exhaust, power plants, and other industrial processes. Although inhalation of •NO2 constitutes the major route for human exposure, other mechanisms exist. In addition to pulmonary exposure, •NO2 can arise from dietary nitrite (NO2 −) and endogenously from nitric oxide (•NO) synthesis [31]. Nitrate and nitrite can occur naturally in the diet from both animal and vegetable sources. Nitrite, under acidic conditions as found in the stomach, can be reduced to •NO2 and NO (Rxn. 10).
Another mechanism for NO2 formation is via the hemolysis reactions of ONOO−/ONOOH in the presence or absence of CO2 (Rxns. 3 and 4) [32]. A third mechanism for •NO2 generation is by peroxidase or metal-mediated nitrite oxidation. Whether nitrite is formed from NO metabolism or derived from dietary sources, it can be enzymatically oxidized to •NO2 by myeloperoxidase (MPO) or eosinophil peroxidase (EPO) (Rxn. 11).
It has also been demonstrated that H2O2 in the presence of heme or free metals (Fe2+, Cu+) forms hypervalent oxo species that readily oxidize NO2 − to •NO2 [33, 34] (Rxns. 12 and 13).
Relevant Biological Reactions
The biological significance of •NO2 formation lies in its unique chemical reactivity. Nitrogen dioxide radical is a strong oxidant that can oxidize (primarily one electron oxidation) proteins, lipids, and nucleic acids, resulting in antioxidant depletion, genetic mutations, and enzyme inhibition. Although highly reactive toward lipids, •NO2 is uncharged and has been shown to diffuse through cell membrane to oxidize intracellular proteins [35]. One of the most important reactions of •NO2 is with tyrosine residues in proteins. In this reaction, •NO2 can both oxidize and add to tyrosine residues to form 3-nitrotyrosien (Rxns. 15 and 16). 3-NT has become an important biomarker associated with numerous pathologies, and its presence is generally considered to be evidence of peroxynitrite formation or •NO2 exposure.
Association with Cancer
Despite its central role in numerous pathologic conditions, very little is known about the biological fate of •NO2 and the mechanisms by which it induces disease-associated phenotypic changes. A variety of studies have been conducted in cell culture systems with various •NO2 exposure paradigms and methodologies. These studies measured a variety of end points such as cell death, inflammatory responses, oxidation, and signaling pathways. When cultured human bronchial epithelial cells (HBEC) were treated with 7520–15,040 μg/m3 of •NO2, cell membrane damage was observed and increased membrane permeability occurred [36]. Another study using more physiologically relevant concentrations of •NO2 (200–800 μg/m3) observed histamine release and other markers of inflammation upon exposure [37]. One study demonstrated that cells exposed to •NO2 (18,800 μg/m3) resulted in cell death in a Fas- and JNK-dependent manner and that log-phase cells were more sensitive than confluent cells [38]. •NO2 has also been shown to suppress NF-κB activation, a pathway essential for survival, after a variety of cellular stresses [39]. When a variety of redox agents (•NO2, O2˙−, CO3 −) were tested for their ability to activate Ras, it was found that •NO2 was able to promote Ras guanine nucleotide dissociation independent of its redox potential [40]. A large meta-analysis concluded that there is a weak association between exposure to •NO2 in ambient air and breast cancer at the individual level and a significant association at the aggregate level [41, 42]. Epidemiologic studies have shown that long-term residential exposure to air pollution and specifically •NO2 was strongly correlated to lung cancer incidence [43, 44]. In another analysis, significant correlation between •NO2 concentrations in urban air pollution and lung, breast, prostate, bladder, cervical, and ovarian cancer incidences was observed [45].
Nitrite (NO2 −, Oxidation State +3)
Biological Sources
Similar to nitrate, nitrite is mainly formed via the oxidation of NO. This process can be an auto-oxidation (Rxn. 17) or be catalyzed by multicopper oxidase or ceruloplasmin (Rxn. 18) [46]. Nevertheless, the major oxidation product of NO remains to be nitrate, as circulating nitrate concentration is in 20–40 μM range while nitrite concentration is about 100- to 10,000-fold lower. Nitrite can also be generated from other nitrogen oxide species such as nitrate via its reduction (described above). The dimerization of nitrogen dioxide radical yields both nitrate and nitrite (Rxn. 4). Dietary nitrite intake comes from processed meat products as nitrite has long been used as a food preservative for cured meats.
Relevant Biological Reactions
Nitrite can be converted back to NO through multiple reductive pathways. The enzymatic pathways for the reduction of nitrite involve a broad range of proteins [47]. In a low pH environment, such as stomach, nitrite is quickly protonated to yield HNO2, which subsequently dimerizes and decomposes to give NO and other nitrogen oxides with nitrosating and nitrating properties (Rxn. 10). One of the products, N2O3, is a potent nitrosating agent that can transfer a NO+ equivalent to secondary amines and form nitrosamines (Rxn. 19).
Association with Cancer
A number of human diet intervention studies and prospective cohort studies have shown correlation between the consumption of nitrite preserved meat and elevated risk in several types of cancer [10]. The same meta-analysis referred to above in the nitrate section also analyzed 51 studies for nitrites and concluded that “dietary nitrite intake was positively associated with adult glioma and thyroid cancer risk”, while no significant association was found with cancers of breast, bladder, and colorectal [11]. Another meta-analysis of studies published from 1985 to 2013 linked the increased consumption of nitrite with higher gastric cancer risk [48]. Again controversial evidence was presented showing no significant association of dietary nitrite with cancer [49, 50]. The mechanisms for nitrite to cause cancer are not completely understood, but the conversion of nitrite to carcinogenic nitrosoamines is considered to be a major cause of increased risk.
Nitric Oxide (•NO, Oxidation State +2)
Biological Sources
Within the human body, there are three main mechanisms for the generation of NO. The primary mechanism is enzymatic from one of the tree isoforms of nitric oxide synthase: NOS1 (nNOS), NOS2 (iNOS), and NOS3 (eNOS). The substrates for these enzymes are molecular oxygen and the amino acid l-arginine, and the products are NO and l-citrulline. Necessary cofactors include FAD, FMN, NADPH, and BH4. The three enzymes differ in their expression levels, cell-type distributions, mechanisms of regulation, K ms for O2, and amounts of NO produced [51]. The second mechanism of NO production is from the reduction of nitrite under hypoxic or acidic conditions (Rxn. 10). A third, albeit minor, source of NO is pharmacological. Organic nitrates such as glyceryl trinitrate (GTN; nitroglycerin) and nitric oxide-releasing non-steroidal antiinflammatory drugs (NO-NSAIDs [52]) can either generate free NO or liberate nitrite which can be further activated to NO. Although a minor contribution to total body NO production under most circumstances, the biological importance of pharmacological NO production can be significant.
Relevant Biological Reactions
Despite the numerous purported biological functions of NO, under biological conditions, it only reacts with two types of molecules: metals and other free radicals. The majority of the reactions of NO with metals are with ferrous iron (Fe2+). Superoxide and molecular oxygen (a diradical) are the most common free radicals to react with NO. Reactions of NO can be divided into two main categories: (1) the formation of other nitrogen oxides (i.e., ONOO−) and (2) the formation of protein adducts containing nitrogen oxide functional groups (i.e., RSNO, see the “Nitrosothiols (RSNO, Oxidation State +1)” section) [23, 53,54,55]. Of all biological targets, one of the potentially most significant and least studied is the chelatable iron pool (CIP). This small, but chemically significant, fraction of total cellular iron (0.2–3.0%, low M range) [56, 57] is methodologically defined because it is accessible to chemical iron chelators [58]. When cells are exposed to NO, the CIP is quantitatively converted into paramagnetic dinitrosyliron complexes with thiol-containing ligands (DNIC) [59, 60]. Quantitative measurements have demonstrated that cellular concentrations of DNIC are proportionally the largest of all NO-derived adducts, much greater than RSNOs [61, 62]. Despite the potential biological importance of DNIC, their functional significance and phenotypic consequences are largely unknown.
Association with Cancer
Active investigations have led to an increasing list of functional roles for NO in cancer biology. The influence of NO spans the spectrum from cancer initiation (being mutagenic), promotion, and progression to even being used therapeutically as an anticancer agent [63]. One of the long standing conundrums in the field of NO and cancer is the fact that NO seems to play dichotomous roles under seemingly similar circumstances [64]. In some cases, NO has been shown to be tumorigenic, and in other circumstances, NO is associated with better patient prognosis. Mechanisms of action of NO in cancer are diverse and include activation of cell signaling cascades, increasing migration/invasion, [59, 65], apoptosis, and recently epigenetics [66, 67]. Biochemical mechanisms of NO result from the participation of many of the reactive nitrogen species discussed herein such as ONOO−, RSNO, and DNIC. Much of the information, however, linking NO to various aspects of cancer etiology in humans is correlative. This is largely based on gene expression data demonstrating that NOS enzymes, most notably NOS2, are upregulated in a variety of more aggressive cancers (breast, lung, prostate, gastrointestinal) [68,69,70]. Given the statistical significance of NOS as a negative prognostic indicator, small molecule NOS inhibitors have been developed and are in various stages of preclinical and clinical developments [71]. In general, the various functions of NO in cancer biology are largely context-specific as phenotypic consequences are uniquely associated with specific tumor types.
Nitrous Oxide (N2O Oxidation State +1)
Biological Sources
Nitrous oxide (N2O), commonly known as “laughing gas”, is a colorless, almost odorless gas first discovered in eighteenth century. More than 60% of the nitrous oxide in atmosphere is liberated from fugal and bacterial respiratory processes as N2O is an intermediate involved in denitrification of the nitrogen cycle [72]. In mammalian cells, it is thought to be formed from the dimerization of HNO and subsequent dehydration (Rxn. 20).
Relevant Biological Reactions and the Association with Cancer
Nitrous oxide has been used as an anesthetic or analgesic agent in surgical procedures and dentistry for centuries. The mechanism of its anesthetic action is likely a result of noncompetitive inhibition of the NMDA subtype of glutamate receptors [73], while the analgesic effect is induced by the activation of opioidergic neurons [74]. The toxicity of nitrous oxide arises from its inhibitory effect on methionine synthase that can lead to genetic and protein aberrations [75,76,77]. A number of studies investigated the effect of nitrous oxide on cancer, yet the results were inconclusive [78]. No strong evidence has been found to associate the exposure of nitrous oxide at the concentration of its clinical use with an increased risk of cancer [75, 78].
Nitrosothiols (RSNO, Oxidation State +1)
Biological Sources
The three most discussed routes yielding RSNO are as follows: (1) NO oxidation to N2O3 followed by reaction with thiols (Rxn. 21), (2) thiyl radicals formed from the reaction of thiols with other oxidants or radicals directly reacting with NO to form RSNO (Rxn. 22), and (3) transition metal ion-catalyzed pathway (although the same transition metals are often good catalysts for RSNO decomposition) [79]. It was reported that thiyl radicals can be formed from small molecular weight thiols during the detoxification of reactive nitrogen/oxygen species or other xenobiotics [80]. The direct reaction of thiyl radical and NO occurs at a diffusion-controlled rate constant (k = 2.7 × 109 M−1 s−1) representing one important route for in vivo RSNO formation [81, 82].
In the presence of transition metal ions like Fe(III) or Cu(II), NO-metal ion complexes are often formed resulting in the reduction of the metal ion and the oxidation of NO to NO+ [83]. The resulting NO+ can either be converted to nitrite in an aqueous environment or form an RSNO when a thiol is also coordinated to the metal center. DNIC formed from the coordination of NO with non-heme iron-sulfur cluster may deliver NO+ to low molecular weight thiols (GSH and cysteine) or protein thiols [84, 85]. In the presence of low level of NO, the reduction of ferric cytochrome c to ferrous cytochrome c and concomitant formation of nitrosoglutathione (GSNO) was observed [86]. Ceruloplasmin, the multicopper-containing protein was shown to catalyze the formation of GSNO and nitrosoalbumin (Rxn. 23) [87]. NO can also interact with methemoglobin (Hb(III)), at a much slower rate than that of the reaction with hemoglobin (Hb(II)), to form Hb(III)NO complex in which NO has NO+ character (Rxn. 24). The NO+ moiety can either transfer to β-93 cysteine to form nitrosohemoglobin (SNOHb) or react with water to form nitrite (Rxn. 25) [88].
Relevant Biological Reactions
The most important reaction of nitrosothiols is transnitrosation in which the nitroso functional group is transferred to another thiol susceptible to the electrophilic attack (Rxn. 26). Transnitrosation represents another possible route to generate new RSNOs although there is no net gain in total nitrosothiols.
When transnitrosation results in the formation of a protein nitrosothiol, this can have significant downstream effects, and this mechanism represents another proposed pathway for the signaling actions of NO. For example, protein S-nitrosation (or nitrosylation) has been widely studied and considered as a critical signaling event in modulating protein function and cellular process, ubiquitous across all organisms [89, 90]. The reverse process of nitrosylation, noted as denitrosylation may occur spontaneously in the presence of transition metals or other nucleophiles or catalyzed by several enzymes like GSNO reductase, thioredoxin, and protein disulfide isomerase [91,92,93]. Another major consequence of RSNO formation is the oxidation of thiols yielding disulfide and hydroxyl (Rxn. 27) [94, 95].
Association with Cancer
Like most diseases associated with NO, there are numerous examples of RSNOs participating in the etiology of cancer. Although too numerous to list, RSNOs have been implicated in diverse aspects of cancer biology [90, 96, 97]. The consequences of protein nitrosothiol formation usually stem from a gain or loss of protein activity/function which results in downstream phenotypic effects. These can include inhibition of enzyme catalytic activity or modulation of transcription factor function. In prostate cancer, increased NO levels were linked to androgen receptor (AR) S-nitrosation and inactivation that lead to growth inhibition [98]. A study on breast cancer cells revealed that the estrogen receptor status may dictate tumor responses to different nitrosative stresses and participate in the development of hormonal resistance [99]. Looking at the role of NO in cancer therapy, it was noted that NO concentration increased significantly in cells that survived cisplatin treatment. The development of resistance to cisplatin was attributed to S-nitrosation of caspase-3 and prolyl-hydroxylase-2, the enzymes responsible for targeting the prosurvival transcription factor hypoxia-inducible factor-1α for proteasomal degradation [100]. A positive role of nitrosothiol formation in cancer therapy was demonstrated in colon cancer cells treated with NO-releasing NSAIDS. These drugs inhibited colon cancer growth by suppressing NF-κB signaling through S-nitrosation [101].
Nitroxyl (NO− or HNO, Oxidation State +1)
Biological Sources
Nitroxyl can be viewed as a one-electron reduction product of NO [102]. Under physiological condition, the predominate form of nitroxyl is the conjugate acid HNO, as the pKa of HNO is 11.5 [103, 104]. Despite the lack of evidence for the endogenous generation of HNO, biochemical mechanisms for in vivo formation of HNO do exist [105, 106]. HNO can be a direct product of NO synthase-catalyzed arginine oxidation [107]. Superoxide dismutase (SOD), mitochondrial cytochrome c, and hemoglobin may all be capable of catalyzing the reduction of NO to HNO [108, 109]. The decomposition of nitrosothiols in the presence of free thiol may also lead to the formation of HNO (Rxn. 27).
Relevant Biological Reactions
HNO is highly unstable, and several reaction routes have been elucidated [110]. The first important reaction of HNO is with metalloproteins. Unlike NO’s preference for ferrous heme, HNO reacts predominately with ferric heme (Fe(III)) to form Fe(II)NO complex through reductive nitrosylation as both metmyoglobin and methemoglobin have been used as efficient traps for HNO in solution (Rxn. 28). Fe(II)NO in the presence of O2 reacts giving rise to NO3 − and Fe(III) (Rxn. 29). Formation of other nitroxyl metal complex with metalloproteins CuZnSOD or MnSOD was reported as well [111]. Another target of HNO is thiols. HNO reacts with thiols (RSH) to form N-hydroxysulfenamide (RSN(H)OH) which can either rearrange to sulfonamide or react with another molecule of RSH to yield RSSR and hydroxylamine (R2NOH) (Rxn. 30 R2NOH = R′SNHOH) [112]. Reactions of HNO with protein thiols have been proposed as a major mechanism for HNO’s pharmacological effect [113, 114]. The reaction rates with thiols can vary, depending on the pKa of the thiol and the hydrophobicity of the thiol environment. In addition to the reactions described above, dimerization of HNO followed by dehydration also occurs at a relatively fast rate (k = 1.8 × 109 M−2 s−1) yielding nitrous oxide (Rxn. 20). The direct reaction of HNO with O2 to form a “peroxynitrite like” species occurs at a much slower rate, and its biological relevance has yet to be elucidated.
Association with Cancer
Evidence for a causative role of HNO in cancer biology has not been presented. However, therapeutically, the anticancer effect of HNO donor compounds has been investigated. HNO has been shown to suppress the proliferation of breast cancer cells and tumor growth in mouse xenograft model, presumably through the initial inhibition of GAPDH and the resulting impairment of energy pathway [115]. The inhibitory effect of HNO donors on PARP, one major enzyme involved in DNA repair, may be utilized to increase the efficacy of chemotherapies and radiation therapy in treating malignancies by inducing DNA damage [116]. Distinct gene expression profile of HNO-donor treated breast cancer cells was observed, providing insights into targets and pathways that can be taken advantage of to develop HNO donor for cancer therapy [117].
Conclusion
Nitrogen oxides are an important class of reactive species involved in the etiology of various diseases and have been implicated, in some form, in almost all stages of cancer development and progression. The biology and pathobiology of nitrogen oxides are largely dictated by the chemical reactions they participate in. The magnitude of the effect of nitrogen oxides on cancer biology is a function of the type of tissue being exposed, as well as the microenvironmental and subcellular characteristics that will determine the types of target molecules. Herein, examples were given for eight major types of RNS that are relevant to cancer (Fig. 1). Although to fully describe the roles of each of these nitrogen oxides in various aspects of cancer is out of the scope of the short review, pertinent examples were given for each to demonstrate their important contributions. In summary, nitrogen oxides can participate in both causative and curative mechanisms of tumor biology. Future research into the complexity and diversity of these reactive species in biological systems will advance our understanding and uncover potential novel therapeutic strategies for cancer.
References
Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002–12.
Wennmalm A, Benthin G, Edlund A, Kieler-Jensen N, Lundin S, Petersson AS, et al. Nitric oxide synthesis and metabolism in man. Ann N Y Acad Sci. 1994;714:158–64.
Eich RF, Li T, Lemon DD, Doherty DH, Curry SR, Aitken JF, et al. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 1996;35:6976–83.
Kissner R, Koppenol WH. Product distribution of peroxynitrite decay as a function of pH, temperature, and concentration. J Am Chem Soc. 2002;124:234–9.
Doyle MP, Hoekstra JW. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem. 1981;14:351–8.
Augusto O, Bonini MG, Amanso AM, Linares E, Santos CC, De Menezes SL. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med. 2002;32:841–59.
Lundberg JO, Weitzberg E, Cole JA, Benjamin N. Nitrate, bacteria and human health. Nat Rev Microbiol. 2004;2:593–602.
Jansson EA, Huang L, Malkey R, Govoni M, Nihlen C, Olsson A, et al. A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat Chem Biol. 2008;4:411–7.
Cheek DB, Habicht JP, Berall J, Holt AB. Protein-calorie malnutrition and the significance of cell mass relative to body length. Am J Clin Nutr. 1977;30:851–60.
Habermeyer M, Roth A, Guth S, Diel P, Engel KH, Epe B, et al. Nitrate and nitrite in the diet: how to assess their benefit and risk for human health. Mol Nutr Food Res. 2015;59:106–28.
Xie L, Mo M, Jia HX, Liang F, Yuan J, Zhu J. Association between dietary nitrate and nitrite intake and site-specific cancer risk: evidence from observational studies. Oncotarget. 2016;7:56915–32.
Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med. 2006;355:2792–3.
Jansson EA, Petersson J, Reinders C, Sobko T, Bjorne H, Phillipson M, et al. Protection from nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers by dietary nitrate. Free Radic Biol Med. 2007;42:510–8.
Dezfulian C, Raat N, Shiva S, Gladwin MT. Role of the anion nitrite in ischemia–reperfusion cytoprotection and therapeutics. Cardiovasc Res. 2007;75:327–38.
Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001;134:1106–14.
Radi R. Peroxynitrite, a stealthy biological oxidant. J Biol Chem. 2013;288:26464–72.
Jourd'heuil D, Lancaster JR Jr, Fukuto J, Roberts DD, Miranda KM, Mayer B, Grisham MB, Wink DA. The bell-shaped curve for peroxynitrite-mediated oxidation and nitration of NO/O2-* is alive and well. J Biol Chem. 2010;285. le15; author reply le16.
Jourd'heuil D, Miranda KM, Kim SM, Espey MG, Vodovotz Y, Laroux S, et al. The oxidative and nitrosative chemistry of the nitric oxide/superoxide reaction in the presence of bicarbonate. Arch Biochem Biophys. 1999;365:92–100.
Kim LB, Kim EB, Kulikov V. Cold resistance estimated on the basis of fetal hemoglobin changes during acute general cooling. Arctic Med Res. 1992;51:32–4.
Espey MG, Thomas DD, Miranda KM, Wink DA. Focusing of nitric oxide mediated nitrosation and oxidative nitrosylation as a consequence of reaction with superoxide. Proc Natl Acad Sci U S A. 2002;99:11127–32.
Denicola A, Freeman BA, Trujillo M, Radi R. Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations. Arch Biochem Biophys. 1996;333:49–58.
Uppu RM, Squadrito GL, Pryor WA. Acceleration of peroxynitrite oxidations by carbon dioxide. Arch Biochem Biophys. 1996;327:335–43.
Jack R, Lancaster J. Reactivity and diffusivity of nitrogen oxides in mammalian biology. In: Signal transduction by reactive oxygen and nitrogen species: pathways and chemical principles. Forman HJ, Fukuto JM, Torres M, editors. Springer; 2003.
Thomas DD, Ridnour LA, Espey MG, Donzelli S, Ambs S, Hussain SP, et al. Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem. 2006;281:25984–93.
Gochman E, Mahajna J, Reznick AZ. NF-kappaB activation by peroxynitrite through IkappaBalpha-dependent phosphorylation versus nitration in colon cancer cells. Anticancer Res. 2011;31:1607–17.
Szaleczky E, Pronai L, Nakazawa H, Tulassay Z. Evidence of in vivo peroxynitrite formation in patients with colorectal carcinoma, higher plasma nitrate/nitrite levels, and lower protection against oxygen free radicals. J Clin Gastroenterol. 2000;30:47–51.
Kondo S, Toyokuni S, Tsuruyama T, Ozeki M, Tachibana T, Echizenya M, et al. Peroxynitrite-mediated stress is associated with proliferation of human metastatic colorectal carcinoma in the liver. Cancer Lett. 2002;179:87–93.
Cobbs CS, Samanta M, Harkins LE, Gillespie GY, Merrick BA, MacMillan-Crow LA. Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch Biochem Biophys. 2001;394:167–72.
Bernardes SS, de Souza-Neto FP, Ramalho LN, Derossi DR, Guarnier FA, da Silva CF, et al. Systemic oxidative profile after tumor removal and the tumor microenvironment in melanoma patients. Cancer Lett. 2015;361:226–32.
Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, et al. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res Off J Am Assoc Cancer Res. 2000;6:4768–75.
Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nature reviews. Drug Discov. 2008;7:156–67.
Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A. 2004;101:4003–8.
Zhang H, Xu Y, Joseph J, Kalyanaraman B. Influence of intramolecular electron transfer mechanism in biological nitration, nitrosation, and oxidation of redox-sensitive amino acids. Methods Enzymol. 2008;440:65–94.
Thomas DD, Espey MG, Vitek MP, Miranda KM, Wink DA. Protein nitration is mediated by heme and free metals through Fenton-type chemistry: an alternative to the NO/O2-reaction. Proc Natl Acad Sci U S A. 2002;99:12691–6.
Espey MG, Xavier S, Thomas DD, Miranda KM, Wink DA. Direct real-time evaluation of nitration with green fluorescent protein in solution and within human cells reveals the impact of nitrogen dioxide vs. peroxynitrite mechanisms. Proc Natl Acad Sci U S A. 2002;99:3481–6.
Devalia JL, Sapsford RJ, Cundell DR, Rusznak C, Campbell AM, Davies RJ. Human bronchial epithelial cell dysfunction following in vitro exposure to nitrogen dioxide. Eur Respir J. 1993;6:1308–16.
Ayyagari VN, Januszkiewicz A, Nath J. Pro-inflammatory responses of human bronchial epithelial cells to acute nitrogen dioxide exposure. Toxicology. 2004;197:149–64.
Shrivastava P, Pantano C, Watkin R, McElhinney B, Guala A, Poynter ML, et al. Reactive nitrogen species-induced cell death requires Fas-dependent activation of c-Jun N-terminal kinase. Mol Cell Biol. 2004;24:6763–72.
Janssen-Heininger YM, Persinger RL, Korn SH, Pantano C, McElhinney B, Reynaert NL, et al. Reactive nitrogen species and cell signaling: implications for death or survival of lung epithelium. Am J Respir Crit Care Med. 2002;166:S9–S16.
Heo J, Campbell SL. Ras regulation by reactive oxygen and nitrogen species. Biochemistry. 2006;45:2200–10.
Keramatinia A, Hassanipour S, Nazarzadeh M, Wurtz M, Monfared AB, Khayyamzadeh M, et al. Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2016;17:419–24.
Hamra GB, Laden F, Cohen AJ, Raaschou-Nielsen O, Brauer M, Loomis D. Lung cancer and exposure to nitrogen dioxide and traffic: a systematic review and meta-analysis. Environ Health Perspect. 2015;123:1107–12.
Hystad P, Demers PA, Johnson KC, Carpiano RM, Brauer M. Long-term residential exposure to air pollution and lung cancer risk. Epidemiology. 2013;24:762–72.
Heinrich J, Thiering E, Rzehak P, Kramer U, Hochadel M, Rauchfuss KM, et al. Long-term exposure to NO2 and PM10 and all-cause and cause-specific mortality in a prospective cohort of women. Occup Environ Med. 2013;70:179–86.
Al-Ahmadi K, Al-Zahrani A. NO(2) and cancer incidence in Saudi Arabia. Int J Environ Res Public Health. 2013;10:5844–62.
Shiva S, Wang X, Ringwood LA, Xu X, Yuditskaya S, Annavajjhala V, et al. Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol. 2006;2:486–93.
Kim-Shapiro DB, Gladwin MT. Mechanisms of nitrite bioactivation. Nitric Oxide. 2014;38:58–68.
Song P, Wu L, Guan W. Dietary nitrates, nitrites, and nitrosamines intake and the risk of gastric cancer: a meta-analysis. Nutrients. 2015;7:9872–95.
Loh YH, Jakszyn P, Luben RN, Mulligan AA, Mitrou PN, Khaw KT. N-nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study. Am J Clin Nutr. 2011;93:1053–61.
Jakszyn P, Bingham S, Pera G, Agudo A, Luben R, Welch A, et al. Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis. 2006;27:1497–501.
Stuehr DJ, Santolini J, Wang ZQ, Wei CC, Adak S. Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem. 2004;279:36167–70.
Abdellatif KR, Abdelall EK, Bakr RB. Nitric oxide-NASIDS donor prodrugs as hybrid safe anti-inflammatory agents. Curr Top Med Chem. 2016.
Hickok JR, Vasudevan D, Jablonski K, Thomas DD. Oxygen dependence of nitric oxide-mediated signaling. Redox Biol. 2013;1:203–9.
Thomas DD. Breathing new life into nitric oxide signaling: a brief overview of the interplay between oxygen and nitric oxide. Redox Biol. 2015;5:225–33.
Thomas DD, Heinecke JL, Ridnour LA, Cheng RY, Kesarwala AH, Switzer CH, et al. Signaling and stress: the redox landscape in NOS2 biology. Free Radic Biol Med. 2015;87:204–25.
Petrat F, de Groot H, Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J. 2001;356:61–9.
Petrat F, de Groot H, Sustmann R, Rauen U. The chelatable iron pool in living cells: a methodically defined quantity. Biol Chem. 2002;383:489–502.
Richardson DR. Molecular mechanisms of iron uptake by cells and the use of iron chelators for the treatment of cancer. Curr Med Chem. 2005;12:2711–29.
Hickok JR, Sahni S, Mikhed Y, Bonini MG, Thomas DD. Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron. J Biol Chem. 2011;286:41413–24.
Pereira JC, Iretskii AV, Han RM, Ford PC. Dinitrosyl iron complexes with cysteine. Kinetics studies of the formation and reactions of DNICs in aqueous solution. J Am Chem Soc. 2015;137:328–36.
Hickok JR, Sahni S, Shen H, Arvind A, Antoniou C, Fung LW, et al. Dinitrosyliron complexes are the most abundant nitric oxide-derived cellular adduct: biological parameters of assembly and disappearance. Free Radic Biol Med. 2011;51:1558–66.
Hickok JR, Vasudevan D, Thatcher GR, Thomas DD. Is S-nitrosocysteine a true surrogate for nitric oxide? Antioxid Redox Signal. 2012;17:962–8.
Hickok JR, Thomas DD. Nitric oxide and cancer therapy: the emperor has NO clothes. Curr Pharm Des. 2010;16:381–91.
Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, et al. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal. 2006;8:1329–37.
Heinecke JL, Ridnour LA, Cheng RY, Switzer CH, Lizardo MM, Khanna C, et al. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression. Proc Natl Acad Sci U S A. 2014;111:6323–8.
Vasudevan D, Hickok JR, Bovee RC, Pham V, Mantell LL, Bahroos N, et al. Nitric oxide regulates gene expression in cancers by controlling histone posttranslational modifications. Cancer Res. 2015;75:5299–308.
Vasudevan D, Bovee RC, Thomas DD. Nitric oxide, the new architect of epigenetic landscapes. Nitric Oxide. 2016;59:54–62.
Basudhar D, Somasundaram V, de Oliveira GA, Kesarwala A, Heinecke JL, Cheng RY, Glynn SA, Ambs S, Wink DA, Ridnour LA. Nitric oxide synthase-2-derived nitric oxide drives multiple pathways of breast cancer progression. Antioxid Redox Signal. 2016.
de Oliveira GA, Cheng RY, Ridnour LA, Basudhar D, Somasundaram V, McVicar DW, Monteiro HP, Wink DA. Inducible nitric oxide synthase in the carcinogenesis of gastrointestinal cancers. Antioxid Redox Signal. 2016.
Burke, A.J., Garrido, P., Johnson, C., Sullivan, F.J., and Glynn, S.A. Inflammation and nitrosative stress effects in ovarian and prostate pathology and carcinogenesis. Antioxid Redox Signal. 2017.
Granados-Principal S, Liu Y, Guevara ML, Blanco E, Choi DS, Qian W, et al. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Res: BCR. 2015;17:25.
Zumft WG. Cell biology and molecular basis of denitrification. Microbiol Mol Biol Rev. 1997;61:533–616.
Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med. 1998;4:460–3.
Fujinaga M, Maze M. Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol. 2002;25:167–89.
Weimann J. Toxicity of nitrous oxide. Best Pract Res Clin Anaesthesiol. 2003;17:47–61.
Sanders RD, Weimann J, Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology. 2008;109:707–22.
Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5:949–60.
Santamaria LB, Schifilliti D, La Torre D, Fodale V. Drugs of anaesthesia and cancer. Surg Oncol. 2010;19:63–81.
Stubauer G, Giuffre A, Sarti P. Mechanism of S-nitrosothiol formation and degradation mediated by copper ions. J Biol Chem. 1999;274:28128–33.
Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711–60.
Madej E, Folkes LK, Wardman P, Czapski G, Goldstein S. Thiyl radicals react with nitric oxide to form S-nitrosothiols with rate constants near the diffusion-controlled limit. Free Radic Biol Med. 2008;44:2013–8.
Lancaster JR Jr. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol. 2006;19:1160–74.
Cooper CE. Nitric oxide and iron proteins. Biochim Biophys Acta. 1999;1411:290–309.
Vanin AF. Dinitrosyl iron complexes with thiolate ligands: physico-chemistry, biochemistry and physiology. Nitric Oxide. 2009;21:1–13.
Bosworth CA, Toledo JC Jr, Zmijewski JW, Li Q, Lancaster JR Jr. Dinitrosyliron complexes and the mechanism(s) of cellular protein nitrosothiol formation from nitric oxide. Proc Natl Acad Sci U S A. 2009;106:4671–6.
Basu S, Keszler A, Azarova NA, Nwanze N, Perlegas A, Shiva S, et al. A novel role for cytochrome c: efficient catalysis of S-nitrosothiol formation. Free Radic Biol Med. 2010;48:255–63.
Inoue K, Akaike T, Miyamoto Y, Okamoto T, Sawa T, Otagiri M, et al. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem. 1999;274:27069–75.
Herold S, Rock G. Reactions of deoxy-, oxy-, and methemoglobin with nitrogen monoxide. Mechanistic studies of the S-nitrosothiol formation under different mixing conditions. J Biol Chem. 2003;278:6623–34.
Stamler JS, Lamas S, Fang FC. Nitrosylation. The prototypic redox-based signaling mechanism. Cell. 2001;106:675–83.
Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005;6:150–66.
Stamler JS, Toone EJ. The decomposition of thionitrites. Curr Opin Chem Biol. 2002;6:779–85.
Espey MG, Miranda KM, Thomas DD, Wink DA. Distinction between nitrosating mechanisms within human cells and aqueous solution. J Biol Chem. 2001;276:30085–91.
Benhar M, Forrester MT, Stamler JS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol. 2009;10:721–32.
Wang YT, Piyankarage SC, Williams DL, Thatcher GR. Proteomic profiling of nitrosative stress: protein S-oxidation accompanies S-nitrosylation. ACS Chem Biol. 2014;9:821–30.
Arnelle DR, Stamler JS. NO+, NO, and NO− donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys. 1995;318:279–85.
Foster MW, Hess DT, Stamler JS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med. 2009;15:391–404.
Wang Z. Protein S-nitrosylation and cancer. Cancer Lett. 2012;320:123–9.
Qin Y, Dey A, Purayil HT, Daaka Y. Maintenance of androgen receptor inactivation by S-nitrosylation. Cancer Res. 2013;73:6690–9.
Canas A, Lopez-Sanchez LM, Valverde-Estepa A, Hernandez V, Fuentes E, Munoz-Castaneda JR, et al. Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors. Breast Cancer Res: BCR. 2012;14:R153.
Godoy LC, Anderson CT, Chowdhury R, Trudel LJ, Wogan GN. Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin. Proc Natl Acad Sci U S A. 2012;109:20373–8.
Chattopadhyay M, Goswami S, Rodes DB, Kodela R, Velazquez CA, Boring D, et al. NO-releasing NSAIDs suppress NF-kappaB signaling in vitro and in vivo through S-nitrosylation. Cancer Lett. 2010;298:204–11.
Bartberger MD, Liu W, Ford E, Miranda KM, Switzer C, Fukuto JM, et al. The reduction potential of nitric oxide (NO) and its importance to NO biochemistry. Proc Natl Acad Sci U S A. 2002;99:10958–63.
Shafirovich V, Lymar SV. Nitroxyl and its anion in aqueous solutions: spin states, protic equilibria, and reactivities toward oxygen and nitric oxide. Proc Natl Acad Sci U S A. 2002;99:7340–5.
Shafirovich V, Lymar SV. Spin-forbidden deprotonation of aqueous nitroxyl (HNO). J Am Chem Soc. 2003;125:6547–52.
Hughes MN. Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. Biochim Biophys Acta. 1999;1411:263–72.
Espey MG, Miranda KM, Thomas DD, Wink DA. Ingress and reactive chemistry of nitroxyl-derived species within human cells. Free Radic Biol Med. 2002;33:827–34.
Hobbs AJ, Fukuto JM, Ignarro LJ. Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci U S A. 1994;91:10992–6.
Murphy ME, Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci U S A. 1991;88:10860–4.
Sharpe MA, Cooper CE. Reactions of nitric oxide with mitochondrial cytochrome c: a novel mechanism for the formation of nitroxyl anion and peroxynitrite. Biochem J. 1998;332(Pt 1):9–19.
Flores-Santana W, Switzer C, Ridnour LA, Basudhar D, Mancardi D, Donzelli S, et al. Comparing the chemical biology of NO and HNO. Arch Pharm Res. 2009;32:1139–53.
Miranda KM, Paolocci N, Katori T, Thomas DD, Ford E, Bartberger MD, et al. A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci U S A. 2003;100:9196–201.
Wong PS, Hyun J, Fukuto JM, Shirota FN, DeMaster EG, Shoeman DW, et al. Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry. 1998;37:5362–71.
Shen B, English AM. Mass spectrometric analysis of nitroxyl-mediated protein modification: comparison of products formed with free and protein-based cysteines. Biochemistry. 2005;44:14030–44.
Fukuto JM, Carrington SJ. HNO signaling mechanisms. Antioxid Redox Signal. 2011;14:1649–57.
Norris AJ, Sartippour MR, Lu M, Park T, Rao JY, Jackson MI, et al. Nitroxyl inhibits breast tumor growth and angiogenesis. Int J Cancer J Int Cancer. 2008;122:1905–10.
Sidorkina O, Espey MG, Miranda KM, Wink DA, Laval J. Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radic Biol Med. 2003;35:1431–8.
Cheng RY, Basudhar D, Ridnour LA, Heinecke JL, Kesarwala AH, Glynn S, et al. Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways. Nitric Oxide. 2014;43:17–28.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
There are no conflicts of interest to declare.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Free Radicals Medicine
Rights and permissions
About this article
Cite this article
Wang, YT., Thomas, D.D. Nitrogen Oxides and Their Roles in Cancer Etiology. Curr Pharmacol Rep 3, 151–161 (2017). https://doi.org/10.1007/s40495-017-0092-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40495-017-0092-3